ProfileGDS5678 / AFFX-GapdhMur/M32599_3_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 111.781599
GSM967853U87-EV human glioblastoma xenograft - Control 212.093999
GSM967854U87-EV human glioblastoma xenograft - Control 312.14999
GSM967855U87-EV human glioblastoma xenograft - Control 411.903599
GSM967856U87-EV human glioblastoma xenograft - Control 512.028599
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 111.791299
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 211.812399
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 311.823999
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 411.777799
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 111.92199
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 211.942999
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 311.871399
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 412.05199
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 511.977299